World's Best Scientists 2026 revealed!
Michael A. Pulsipher

Michael A. Pulsipher

D-Index & Metrics

Medicine

D-Index
83
Citations
28046
World Ranking
15516
National Ranking
7821

Overview

Michael A. Pulsipher is affiliated with the University of Utah in the United States. Their research primarily focuses on medicine, with substantial contributions to hematology, oncology, immunology, public health, environmental and occupational health, and genetics. Their work encompasses several specialized topics related to hematopoietic stem cell transplantation, CAR-T cell therapy research, and various forms of leukemia, particularly acute lymphoblastic leukemia (ALL).

The scientist has contributed extensively to research on these main topics:

  • Hematopoietic Stem Cell Transplantation
  • CAR-T cell therapy research
  • Acute Lymphoblastic Leukemia research
  • Immunodeficiency and Autoimmune Disorders
  • Childhood Cancer Survivors' Quality of Life
  • Acute Myeloid Leukemia Research
  • Immune Cell Function and Interaction

Michael A. Pulsipher has published numerous papers in well-regarded journals. Some recent publications include:

  • Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma, 2020, Blood Advances
  • Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia, 2021, JAMA
  • Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial, 2022, Journal of Clinical Oncology
  • Immunogenicity of CAR T cells in cancer therapy, 2021, Nature Reviews Clinical Oncology
  • Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD, 2021, Journal of Clinical Oncology

Their work frequently appears in several publication venues, including:

  • Blood
  • Transplantation and Cellular Therapy
  • Blood Advances
  • Biology of Blood and Marrow Transplantation
  • Clinical Immunology

Michael A. Pulsipher collaborates regularly with several researchers. Frequent co-authors include:

  • Christopher C. Dvorak
  • Sung-Yun Pai
  • Brent R. Logan
  • Donald B. Kohn
  • Élie Haddad

Best Publications

  • Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

    S. L. Maude;Theodore W Laetsch;J. Buechner;S. Rives

  • Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors

    Claudio Anasetti;Brent R. Logan;Stephanie J. Lee;Edmund K. Waller

  • Transplantation Outcomes for Severe Combined Immunodeficiency, 2000–2009

    Sung Yun Pai;Brent R. Logan;Linda M. Griffith;Rebecca H. Buckley

  • Comorbidity-Age Index: A Clinical Measure of Biologic Age Before Allogeneic Hematopoietic Cell Transplantation

    Mohamed L. Sorror;Rainer F. Storb;Brenda M. Sandmaier;Richard T. Maziarz

  • Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma.

    Marcelo C. Pasquini;Zhen-Huan Hu;Kevin Curran;Theodore Laetsch

  • HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies.

    Michael B. Maris;Dietger Niederwieser;Brenda M. Sandmaier;Barry Storer

  • Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma

    Michael B. Maris;Brenda M. Sandmaier;Barry E. Storer;Thomas Chauncey

  • Comparison of Outcomes of HLA-Matched Related, Unrelated, or HLA-Haploidentical Related Hematopoietic Cell Transplantation following Nonmyeloablative Conditioning for Relapsed or Refractory Hodgkin Lymphoma

    Lauri M. Burroughs;Paul V. O'Donnell;Brenda M. Sandmaier;Barry E. Storer

  • Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.

    Mohamed L. Sorror;Barry E. Storer;Brenda M. Sandmaier;Michael Maris

  • Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation

    Mohamed Sorror;Barry Storer;Barry Storer;Brenda M. Sandmaier;Brenda M. Sandmaier;David G. Maloney;David G. Maloney

  • Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program

    Michael A. Pulsipher;Pintip Chitphakdithai;John P. Miller;Brent R. Logan

  • Long-Term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies

    Mohamed L. Sorror;Brenda M. Sandmaier;Brenda M. Sandmaier;Barry E. Storer;Barry E. Storer;Georg N. Franke

  • Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS.

    Selina M. Luger;Olle Ringdén;Mei-Jie Zhang;Waleska S. Pérez

  • The Fanconi anaemia proteins, FAA and FAC, interact to form a nuclear complex.

    Gary M. Kupfer;Dieter Näf;Ahmed Suliman;Michael Pulsipher

  • Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study.

    Jennifer Heimall;Brent R. Logan;Morton J. Cowan;Luigi D. Notarangelo

  • Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Advanced Chronic Lymphocytic Leukemia

    Mohamed L. Sorror;Michael B. Maris;Brenda M. Sandmaier;Barry E. Storer

  • Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)

    Naynesh R. Kamani;Mark C. Walters;Shelly Carter;Victor Aquino

  • Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial

    Patrick A. Brown;Lingyun Ji;Xinxin Xu;Meenakshi Devidas

  • Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia

    Boglarka Gyurkocza;Rainer Storb;Barry E. Storer;Thomas R. Chauncey

  • Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation

    Rainer Storb;Boglarka Gyurkocza;Boglarka Gyurkocza;Barry E. Storer;Barry E. Storer;Mohamed L. Sorror;Mohamed L. Sorror

Frequent Co-Authors

Brenda M. Sandmaier
Brenda M. Sandmaier Fred Hutchinson Cancer Research Center
Rainer Storb
Rainer Storb Fred Hutchinson Cancer Research Center
David G. Maloney
David G. Maloney Fred Hutchinson Cancer Research Center
Barry E. Storer
Barry E. Storer Fred Hutchinson Cancer Research Center
Brent R. Logan
Brent R. Logan Medical College of Wisconsin
Stephan A. Grupp
Stephan A. Grupp Children's Hospital of Philadelphia
John E. Levine
John E. Levine Icahn School of Medicine at Mount Sinai
Richard T. Maziarz
Richard T. Maziarz Oregon Health & Science University
Mary M. Horowitz
Mary M. Horowitz Medical College of Wisconsin
Michael Boyer
Michael Boyer University of Utah

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in the healthcare field but aren’t set on medical school, several flexible online degrees can jumpstart your career. Many students explore affordable online nursing programs, which offer quality education at a lower cost and often allow you to study while working.

For those who already hold a registered nursing license, an rn to bsn online cost comparison can help you find budget-friendly options to advance your qualifications. If you’re aiming higher, consider online nursing doctoral programs for a fast track to leadership or research roles.

Professionals with a bachelor’s degree in another field can enter the profession quickly through online msn programs for non nurses, offering direct entry into nursing with minimal prerequisites. As the demand for skilled healthcare professionals grows, choosing the right online path can open up new opportunities in patient care, administration, teaching, or research.

Discover a range of online nursing doctoral programs designed for working adults—further proof that you don’t need to put your life on hold to advance your career in healthcare.

Best Scientists Citing Michael A. Pulsipher

Trending Scientists